Daniela Bianconi

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 2

Top Topics

Patient Reported Outcomes

Top Venues

Medical oncology (Northwood, London, England)

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Daniela Bianconi, Merima Herac, Florian Posch, Margit Schmeidl, Matthias Unseld, Markus Kieler, Robert Brettner, Leonhard Müllauer, Jakob Riedl, Armin Gerger, Werner Scheithauer, Gerald Prager
Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC. Therapeutic advances in medical oncology 12 (2020)
Markus Kieler, Matthias Unseld, Johann Wojta, Alexandra Kaider, Daniela Bianconi, Svitlana Demyanets, Gerald W Prager
Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy. Medical oncology (Northwood, London, England) 36 (1) (2018)